Pear Therapeutics

📍 Boston, United States🗓 Founded 2013👥 52 employees💰 Last funded Jan 2019
Biotechnology Research🌐 peartherapeutics.com
Website LinkedIn
Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.
10
Total investors
0
Early stage
9
Mid stage
1
Late stage
2013
Founded

Investors

10 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
9
Investor activity2016–2019 · investors recorded per year
201632017620191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Pear Therapeutics?
Pear Therapeutics has 10 investors on record on gritt.io, 9 mid-stage and 1 late-stage investors.
When did Pear Therapeutics last raise funding?
The most recent investment in Pear Therapeutics recorded on gritt.io was in January 2019.
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
What industry is Pear Therapeutics in?
Pear Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pear Therapeutics based?
Pear Therapeutics is headquartered in Boston, United States.